// App-Quantinova.ai

S2-02 : The landscape of somatic genetic alterations in BRCA1 and BRCA2 breast cancers

Researchers

Presenter

  • FC Geyer

Principal Investigators

  • KA Burke

  • GS Macedo

  • S Piscuoglio

  • CK Ng

  • LG Martelotto

  • AD Papanastatiou

  • MR De Filippo

  • AM Schultheis

  • E Brogi

  • M Robson

  • YH Wen

  • B Weigelt

  • SJ Schnitt

  • N Tung

  • JS Reis-Filho

Medical Centers

  • Beth Israel Deaconess Medical Center, Boston, MA

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Phosphatase and tensin homolog

  • Cyclin Dependent Kinase Inhibitor 2A

  • Retinoblastoma protein

  • Tumor protein p53

  • Neurofibromatosis type 1

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved